Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Barohn

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of Clinical Neuromuscular Disease|December 17, 2008
Myasthenia gravis, thymoma, and intestinal pseudo-obstruction: a case report and reviewGoran Rakocevic, Richard Barohn, April L McVey, et al.
The International Journal of Neuroscience|July 13, 2012
Benefit of Qigong exercise in patients with fibromyalgia: a pilot studyWen Liu, Laura Zahner, Molly Cornell, et al.
Muscle & Nerve|September 7, 2017
An instrumented timed up and go in facioscapulohumeral muscular dystrophyJessie Huisinga, Adam Bruetsch, Ayla Mccalley, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 6, 2014
NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker studyRobert G Miller, Rongzhen Zhang, Gilbert Block, et al.
Arthritis Care & Research|May 17, 2012
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)Lisa G Rider, Victoria P Werth, Adam M Huber, et al.
The International Journal of Neuroscience|March 7, 2013
North America and South America (NA-SA) neuropathy projectMamatha Pasnoor, Osvaldo J M Nascimento, Jaya Trivedi, et al.
Brain : a Journal of Neurology|March 1, 2014
Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlationTracey D Graves, Yoon-Hee Cha, Angelika F Hahn, et al.
Orphanet Journal of Rare Diseases|August 26, 2017
A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe diseaseBarry J Byrne, Tarekegn Geberhiwot, Bruce A Barshop, et al.
Muscle & Nerve|January 31, 2022
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analysesRobert G Miller, Rongzhen Zhang, Paige M Bracci, et al.
Molecular Genetics and Metabolism|October 4, 2012
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfaAns T van der Ploeg, Richard Barohn, Lisa Carlson, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Neuromuscular Disease|December 17, 2008
Myasthenia gravis, thymoma, and intestinal pseudo-obstruction: a case report and reviewGoran Rakocevic, Richard Barohn, April L McVey, et al.
The International Journal of Neuroscience|July 13, 2012
Benefit of Qigong exercise in patients with fibromyalgia: a pilot studyWen Liu, Laura Zahner, Molly Cornell, et al.
Muscle & Nerve|September 7, 2017
An instrumented timed up and go in facioscapulohumeral muscular dystrophyJessie Huisinga, Adam Bruetsch, Ayla Mccalley, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 6, 2014
NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker studyRobert G Miller, Rongzhen Zhang, Gilbert Block, et al.
Arthritis Care & Research|May 17, 2012
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)Lisa G Rider, Victoria P Werth, Adam M Huber, et al.
The International Journal of Neuroscience|March 7, 2013
North America and South America (NA-SA) neuropathy projectMamatha Pasnoor, Osvaldo J M Nascimento, Jaya Trivedi, et al.
Brain : a Journal of Neurology|March 1, 2014
Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlationTracey D Graves, Yoon-Hee Cha, Angelika F Hahn, et al.
Orphanet Journal of Rare Diseases|August 26, 2017
A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe diseaseBarry J Byrne, Tarekegn Geberhiwot, Bruce A Barshop, et al.
Muscle & Nerve|January 31, 2022
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analysesRobert G Miller, Rongzhen Zhang, Paige M Bracci, et al.
Molecular Genetics and Metabolism|October 4, 2012
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfaAns T van der Ploeg, Richard Barohn, Lisa Carlson, et al.
Pageof 4